US · USD
UTHR
United Therapeutics Corporation
- Day's range
- $541.27 – $577.02
- Day's volume
- $506.9M
- 52-week range
- $415.34 – $596.76
Follow UTHR in the Fuolio
See how UTHR weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountUTHR in numbers
- Market cap
- $23.2B
- P/E
- 17.55
- P/B
- 3.59
- Dividend yield (12m)
- 0.00%
UTHR trades at 17.55 times its earnings of the last 12 months.
UTHR price history
UTHR risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +11.46% | +125.71% | +185.86% |
| Volatility (annualized) | 22.22% | 32.43% | 33.89% |
| Largest drawdown | -13.93% | -26.54% | -26.54% |
| Positive months | 4/12 | 16/36 | 27/60 |
How much did investing in UTHR return?
$1,000.00 invested on 11/01/2021 would be worth $2,830.61 today.
- Value today in UTHR
- $2,830.61
- Return over the period
- +183.06%
- Return per year
- +23.52%
- In the S&P 500
- $1,702.20
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
UTHR fundamentals
Valuation
- P/E17.55
- P/B3.59
- EV/EBITDA15.56
- EV/EBIT16.57
- EV/Revenue7.37
- P/EBIT16.57
- P/S7.37
- P/OCF13.79
- P/FCF21.26
- Earnings yield6.03%
- PEG ratio—
- Earnings per share$30.56
- Book value per share$149.22
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio5.73
- Quick ratio5.41
- Cash ratio4.38
Efficiency
- Gross margin86.14%
- EBITDA margin47.34%
- Operating margin44.44%
- Net margin41.56%
- Asset turnover0.44
Profitability
- ROE20.48%
- ROA18.16%
- ROIC18.25%
- Payout0.00%
Growth
- Revenue CAGR (5 years)14.68%
- Earnings CAGR (5 years)—
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
What is UTHR's fair price?
Two classic value formulas, with today's numbers. The current price is $536.40.
- Graham's fair price
- $320.34
- 40.28% below the price
√(22.50 × $30.56 × $149.22)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- —
- Does not apply to UTHR: it paid no distributions in the last five years.
Décio Bazin only bought stocks yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years over 6%.
Graham ignores growth and debt; Bazin assumes past distributions repeat. They are references to compare, not a buy recommendation.
UTHR's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 16.00 | 13.26 | 10.51 | 17.70 | 20.50 | — | — | — |
| P/B | 3.01 | 2.46 | 1.73 | 2.68 | 2.46 | 1.99 | 1.39 | 1.71 |
| EV/EBITDA | 13.53 | 10.93 | 8.36 | 12.49 | 16.10 | 10.51 | — | 5.66 |
| Earnings per share | $30.45 | $26.61 | $20.93 | $15.71 | $10.54 | — | — | — |
| Book value per share | $161.91 | $143.48 | $127.18 | $103.60 | $87.72 | $76.22 | $63.36 | $63.78 |
| ROE | 18.81% | 18.55% | 16.46% | 15.16% | 12.02% | — | — | — |
| ROIC | 16.38% | 16.59% | 15.30% | 15.63% | 11.25% | 14.09% | -4.27% | 22.42% |
| Gross margin | 87.92% | 89.24% | 88.94% | 92.17% | 92.73% | 92.71% | 91.88% | 87.79% |
| EBITDA margin | 49.58% | 50.38% | 53.19% | 53.25% | 35.94% | 43.38% | -9.78% | 51.68% |
| Net margin | 41.94% | 41.53% | 42.31% | 37.56% | 28.23% | — | — | — |
UTHR's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $3.2B | $2.9B | $2.3B | $1.9B | $1.7B | $1.5B |
| Cost of revenue | -$384.4M | -$309.7M | -$257.5M | -$151.6M | -$122.5M | -$108.1M |
| Gross profit | $2.8B | $2.6B | $2.1B | $1.8B | $1.6B | $1.4B |
| EBITDA | $1.6B | $1.4B | $1.2B | $1B | $605.8M | $643.5M |
| EBIT | $1.5B | $1.4B | $1.2B | $979.7M | $555.9M | $593.6M |
| Financial result | $221.4M | $162M | $89.4M | -$29.1M | $38M | $45.3M |
| Income before tax | $1.7B | $1.5B | $1.3B | $950.6M | $593.9M | $638.9M |
| Income tax | -$379.2M | -$343.9M | -$289.5M | -$223.3M | -$118.1M | -$124.1M |
| Net income | $1.3B | $1.2B | $984.8M | $727.3M | $475.8M | — |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does UTHR pay dividends?
UTHR has no distributions on record.
About United Therapeutics
- Sector
- Manufacturing
Questions about UTHR
How much is UTHR today?
UTHR is at $536.40 (-6.12% on the day), last traded on 10/05/2026.
What are the P/E and P/B of UTHR?
UTHR trades at a P/E of 17.55 and a P/B of 3.59.
How much did UTHR return in 12 months?
UTHR returned 11.46% in 12 months, with annualized volatility of 22.22% and a largest drawdown of -13.93%.